Industry Research Reports
Home > Reports > Pharma & Healthcare > Global Sevoflurane Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
Global Sevoflurane Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
Industry: Pharma & Healthcare
Published Date: 2026-01-04
Pages: 78 Pages
Report ld: 5554901
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Sevoflurane Market Size(US$)
CAGR 2026-2032
3.6%
Market Size,2032
USD 1,577
Million
Market Snapshot
Market Size in 2026 (Value)
US$ 1,274 million
Market Forecast in 2032(Value)
US$ 1,577 million
CAGR
3.6%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Sevoflurane market size was US$ 1234 million in 2025 and is forecast to reach a readjusted size of US$ 1577 million by 2032 with a CAGR of 3.6% during the forecast period 2026-2032.
Sevoflurane is a volatile anesthetic commonly used for induction and maintenance of general anesthesia during surgical procedures. It is favored for its rapid onset and offset of action, making it ideal for both adults and pediatric patients. Sevoflurane is typically inhaled and works by depressing the central nervous system, leading to a reversible loss of consciousness and sensation. Its minimal airway irritation and low blood solubility contribute to smoother anesthesia induction and quicker recovery times compared to other anesthetics. Sevoflurane is widely used due to its safety profile and ease of administration.
The key driver for the Sevoflurane market is the increasing number of surgeries worldwide, driven by the aging population and the rising prevalence of chronic conditions requiring surgical intervention. Sevoflurane is highly preferred due to its rapid onset and recovery, making it ideal for both pediatric and adult patients, particularly in outpatient surgeries. Technological advancements in anesthesia delivery systems and the growing demand for minimally invasive procedures have also contributed to the rising adoption of Sevoflurane in clinical settings. Furthermore, the safety and effectiveness of Sevoflurane in maintaining stable cardiovascular function during anesthesia have enhanced its demand.
One of the main challenges in the Sevoflurane market is its high cost compared to other anesthetic agents, which can limit its accessibility in low- and middle-income regions. Additionally, environmental concerns regarding the use of volatile anesthetics like Sevoflurane, which contribute to greenhouse gas emissions, have led to increased scrutiny and calls for more sustainable alternatives. Regulatory restrictions and the availability of generic alternatives may further impact the market growth, as healthcare providers seek more cost-effective or environmentally friendly options.
The global Sevoflurane market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2021-2032.
MARKET SEGMENTATION
By Company
- Hengrui
- Baxter
- Maruishi
- AbbVie
- Piramal
- Viatris
- PT Novell Pharmaceutical
- Lunan Pharma
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Generic Drug
- Original Drug
Segment by Application
- Hospital
- Clinics
- Other
CHAPTER OUTLINE
Chapter 1: Report scope, segment-level executive summary (by Type, by Application) and market evolution across the short, mid and long term
Chapter 2: Quantitative analysis of Sevoflurane sales and revenue at global, regional, and country levels, highlighting market size and growth potential by region
Chapter 3: Competitive landscape of Sevoflurane manufacturers (sales, revenue, pricing, market share, industry rankings, and M&A / expansion plans)
Chapter 4: by Type-based segmentation analysis (sales, revenue, pricing, and growth potential) to identify blue-ocean product segments
Chapter 5: by Application-based segmentation analysis (sales, revenue, pricing, and growth potential) to uncover high-value downstream markets
Chapter 6: Regional breakdown by company, customer, by Type and by Application (sales, revenue, and pricing for each segment)
Chapter 7: Key manufacturer profiles –company overview, Sevoflurane product descriptions and specifications, revenue, gross margins, and recent developments
Chapter 8: Industry chain analysis – upstream raw materials, manufacturing links, and downstream application sectors
Chapter 9: Sales channels and distributor analysis – routes to market and key customer interfaces
Chapter 10: Market dynamics – trends, drivers, restraints, risks for manufacturers, and the impact of relevant industry policies
Chapter 11: Key findings, main takeaways, and overall conclusions of the report.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Sevoflurane value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Sevoflurane Product Scope
1.2 Sevoflurane by Type
1.2.1 Global Sevoflurane Sales by Type (2021, 2025 & 2032)
1.2.2 Generic Drug
1.2.3 Original Drug
1.3 Sevoflurane by Application
1.3.1 Global Sevoflurane Sales Comparison by Application (2021, 2025 & 2032)
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Other
1.4 Global Sevoflurane Market Estimates and Forecasts (2021-2032)
1.4.1 Global Sevoflurane Market Size (Value) and Growth Rate (2021-2032)
1.4.2 Global Sevoflurane Market Size (Volume) and Growth Rate (2021-2032)
1.4.3 Global Sevoflurane Price Trends (2021-2032)
1.5 Assumptions and Limitations
2 Market Size and Prospects by Region
2.1 Global Sevoflurane Market Size by Region: 2021 VS 2025 VS 2032
2.2 Global Sevoflurane Historical Market Scenario by Region (2021-2026)
2.2.1 Global Sevoflurane Sales Market Share by Region (2021-2026)
2.2.2 Global Sevoflurane Revenue Market Share by Region (2021-2026)
2.3 Global Sevoflurane Market Estimates and Forecasts by Region (2027-2032)
2.3.1 Global Sevoflurane Sales Estimates and Forecasts by Region (2027-2032)
2.3.2 Global Sevoflurane Revenue Forecast by Region (2027-2032)
2.4 Major Regions and Emerging Market Analysis
2.4.1 North America Sevoflurane Market Size and Prospects (2021-2032)
2.4.2 Europe Sevoflurane Market Size and Prospects (2021-2032)
2.4.3 China Sevoflurane Market Size and Prospects (2021-2032)
2.4.4 Japan Sevoflurane Market Size and Prospects (2021-2032)
2.4.5 India Sevoflurane Market Size and Prospects (2021-2032)
3 Global Market Size by Type
3.1 Global Sevoflurane Historical Market Review by Type (2021-2026)
3.1.1 Global Sevoflurane Sales by Type (2021-2026)
3.1.2 Global Sevoflurane Revenue by Type (2021-2026)
3.1.3 Global Sevoflurane Average Price by Type (2021-2026)
3.2 Global Sevoflurane Market Estimates and Forecasts by Type (2027-2032)
3.2.1 Global Sevoflurane Sales Forecast by Type (2027-2032)
3.2.2 Global Sevoflurane Revenue Forecast by Type (2027-2032)
3.2.3 Global Sevoflurane Price Forecast by Type (2027-2032)
3.3 Representative Players for Different Types of Sevoflurane
4 Global Market Size by Application
4.1 Global Sevoflurane Historical Market Review by Application (2021-2026)
4.1.1 Global Sevoflurane Sales by Application (2021-2026)
4.1.2 Global Sevoflurane Revenue by Application (2021-2026)
4.1.3 Global Sevoflurane Average Price by Application (2021-2026)
4.2 Global Sevoflurane Market Estimates and Forecasts by Application (2027-2032)
4.2.1 Global Sevoflurane Sales Forecast by Application (2027-2032)
4.2.2 Global Sevoflurane Revenue Forecast by Application (2027-2032)
4.2.3 Global Sevoflurane Price Forecast by Application (2027-2032)
4.3 New Sources of Growth in Sevoflurane Applications
5 Competition Landscape by Players
5.1 Global Sevoflurane Sales by Player (2021-2026)
5.2 Global Top Sevoflurane Players by Revenue (2021-2026)
5.3 Global Sevoflurane Market Share by Company Type (Tier 1, Tier 2, and Tier 3), based on Sevoflurane revenue as of 2025
5.4 Global Sevoflurane Average Price by Company (2021-2026)
5.5 Global Key Manufacturers of Sevoflurane, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Sevoflurane, Product Type & Application
5.7 Global Key Manufacturers of Sevoflurane, Date of Entry into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Regional Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Sevoflurane Sales by Company
6.1.1.1 North America Sevoflurane Sales by Company (2021-2026)
6.1.1.2 North America Sevoflurane Revenue by Company (2021-2026)
6.1.2 North America Sevoflurane Sales Breakdown by Type (2021-2026)
6.1.3 North America Sevoflurane Sales Breakdown by Application (2021-2026)
6.1.4 North America Sevoflurane Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Sevoflurane Sales by Company
6.2.1.1 Europe Sevoflurane Sales by Company (2021-2026)
6.2.1.2 Europe Sevoflurane Revenue by Company (2021-2026)
6.2.2 Europe Sevoflurane Sales Breakdown by Type (2021-2026)
6.2.3 Europe Sevoflurane Sales Breakdown by Application (2021-2026)
6.2.4 Europe Sevoflurane Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Sevoflurane Sales by Company
6.3.1.1 China Sevoflurane Sales by Company (2021-2026)
6.3.1.2 China Sevoflurane Revenue by Company (2021-2026)
6.3.2 China Sevoflurane Sales Breakdown by Type (2021-2026)
6.3.3 China Sevoflurane Sales Breakdown by Application (2021-2026)
6.3.4 China Sevoflurane Major Customers
6.3.5 China Market Trends and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Sevoflurane Sales by Company
6.4.1.1 Japan Sevoflurane Sales by Company (2021-2026)
6.4.1.2 Japan Sevoflurane Revenue by Company (2021-2026)
6.4.2 Japan Sevoflurane Sales Breakdown by Type (2021-2026)
6.4.3 Japan Sevoflurane Sales Breakdown by Application (2021-2026)
6.4.4 Japan Sevoflurane Major Customers
6.4.5 Japan Market Trends and Opportunities
6.5 India Market: Players, Segments, Downstream and Major Customers
6.5.1 India Sevoflurane Sales by Company
6.5.1.1 India Sevoflurane Sales by Company (2021-2026)
6.5.1.2 India Sevoflurane Revenue by Company (2021-2026)
6.5.2 India Sevoflurane Sales Breakdown by Type (2021-2026)
6.5.3 India Sevoflurane Sales Breakdown by Application (2021-2026)
6.5.4 India Sevoflurane Major Customers
6.5.5 India Market Trends and Opportunities
7 Company Profiles and Key Figures
7.1 Hengrui
7.1.1 Hengrui Company Information
7.1.2 Hengrui Business Overview
7.1.3 Hengrui Sevoflurane Sales, Revenue and Gross Margin (2021-2026)
7.1.4 Hengrui Sevoflurane Products Offered
7.1.5 Hengrui Recent Development
7.2 Baxter
7.2.1 Baxter Company Information
7.2.2 Baxter Business Overview
7.2.3 Baxter Sevoflurane Sales, Revenue and Gross Margin (2021-2026)
7.2.4 Baxter Sevoflurane Products Offered
7.2.5 Baxter Recent Development
7.3 Maruishi
7.3.1 Maruishi Company Information
7.3.2 Maruishi Business Overview
7.3.3 Maruishi Sevoflurane Sales, Revenue and Gross Margin (2021-2026)
7.3.4 Maruishi Sevoflurane Products Offered
7.3.5 Maruishi Recent Development
7.4 AbbVie
7.4.1 AbbVie Company Information
7.4.2 AbbVie Business Overview
7.4.3 AbbVie Sevoflurane Sales, Revenue and Gross Margin (2021-2026)
7.4.4 AbbVie Sevoflurane Products Offered
7.4.5 AbbVie Recent Development
7.5 Piramal
7.5.1 Piramal Company Information
7.5.2 Piramal Business Overview
7.5.3 Piramal Sevoflurane Sales, Revenue and Gross Margin (2021-2026)
7.5.4 Piramal Sevoflurane Products Offered
7.5.5 Piramal Recent Development
7.6 Viatris
7.6.1 Viatris Company Information
7.6.2 Viatris Business Overview
7.6.3 Viatris Sevoflurane Sales, Revenue and Gross Margin (2021-2026)
7.6.4 Viatris Sevoflurane Products Offered
7.6.5 Viatris Recent Development
7.7 PT Novell Pharmaceutical
7.7.1 PT Novell Pharmaceutical Company Information
7.7.2 PT Novell Pharmaceutical Business Overview
7.7.3 PT Novell Pharmaceutical Sevoflurane Sales, Revenue and Gross Margin (2021-2026)
7.7.4 PT Novell Pharmaceutical Sevoflurane Products Offered
7.7.5 PT Novell Pharmaceutical Recent Development
7.8 Lunan Pharma
7.8.1 Lunan Pharma Company Information
7.8.2 Lunan Pharma Business Overview
7.8.3 Lunan Pharma Sevoflurane Sales, Revenue and Gross Margin (2021-2026)
7.8.4 Lunan Pharma Sevoflurane Products Offered
7.8.5 Lunan Pharma Recent Development
8 Sevoflurane Manufacturing Cost Analysis
8.1 Sevoflurane Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Sevoflurane
8.4 Sevoflurane Industrial Chain Analysis
9 Marketing Channels, Distributors and Customers
9.1 Marketing Channels
9.2 Sevoflurane Distributors List
9.3 Sevoflurane Customers
10 Sevoflurane Market Dynamics
10.1 Sevoflurane Industry Trends
10.2 Sevoflurane Market Drivers
10.3 Sevoflurane Market Challenges
10.4 Sevoflurane Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Sevoflurane Sales (US$ Million) Growth Rate by Type (2021, 2025 & 2032)
Table 2. Global Sevoflurane Sales (US$ Million) Comparison by Application (2021, 2025 & 2032)
Table 3. Global Market Sevoflurane Market Size (US$ Million) by Region:2021 VS 2025 VS 2032
Table 4. Global Sevoflurane Sales (K Units) by Region (2021-2026)
Table 5. Global Sevoflurane Sales Market Share by Region (2021-2026)
Table 6. Global Sevoflurane Revenue (US$ Million) Market Share by Region (2021-2026)
Table 7. Global Sevoflurane Revenue Share by Region (2021-2026)
Table 8. Global Sevoflurane Sales (K Units) Forecast by Region (2027-2032)
Table 9. Global Sevoflurane Sales Market Share Forecast by Region (2027-2032)
Table 10. Global Sevoflurane Revenue (US$ Million) Forecast by Region (2027-2032)
Table 11. Global Sevoflurane Revenue Share Forecast by Region (2027-2032)
Table 12. Global Sevoflurane Sales by Type (K Units) & (2021-2026)
Table 13. Global Sevoflurane Sales Share by Type (2021-2026)
Table 14. Global Sevoflurane Revenue by Type (US$ Million) & (2021-2026)
Table 15. Global Sevoflurane Average Price by Type (US$/Unit) & (2021-2026)
Table 16. Global Sevoflurane Sales by Type (K Units) & (2027-2032)
Table 17. Global Sevoflurane Revenue by Type (US$ Million) & (2027-2032)
Table 18. Global Sevoflurane Average Price by Type (US$/Unit) & (2027-2032)
Table 19. Representative Players of Each Type
Table 20. Global Sevoflurane Sales by Application (K Units) & (2021-2026)
Table 21. Global Sevoflurane Sales Share by Application (2021-2026)
Table 22. Global Sevoflurane Revenue by Application (US$ Million) & (2021-2026)
Table 23. Global Sevoflurane Average Price by Application (US$/Unit) & (2021-2026)
Table 24. Global Sevoflurane Sales by Application (K Units) & (2027-2032)
Table 25. Global Sevoflurane Revenue Market Share by Application (US$ Million) & (2027-2032)
Table 26. Global Sevoflurane Average Price by Application (US$/Unit) & (2027-2032)
Table 27. New Sources of Growth in Sevoflurane Applications
Table 28. Global Sevoflurane Sales by Company (K Units) & (2021-2026)
Table 29. Global Sevoflurane Sales Share by Company (2021-2026)
Table 30. Global Sevoflurane Revenue by Company (US$ Million) & (2021-2026)
Table 31. Global Sevoflurane Revenue Share by Company (2021-2026)
Table 32. Global Sevoflurane by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sevoflurane as of 2025)
Table 33. Global Market Sevoflurane Average Price by Company (US$/Unit) & (2021-2026)
Table 34. Global Key Manufacturers of Sevoflurane, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Sevoflurane, Product Type & Application
Table 36. Global Key Manufacturers of Sevoflurane, Date of Entry into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Sevoflurane Sales by Company (2021-2026) & (K Units)
Table 39. North America Sevoflurane Sales Market Share by Company (2021-2026)
Table 40. North America Sevoflurane Revenue by Company (2021-2026) & (US$ Million)
Table 41. North America Sevoflurane Revenue Market Share by Company (2021-2026)
Table 42. North America Sevoflurane Sales by Type (2021-2026) & (K Units)
Table 43. North America Sevoflurane Sales Market Share by Type (2021-2026)
Table 44. North America Sevoflurane Sales by Application (2021-2026) & (K Units)
Table 45. North America Sevoflurane Sales Market Share by Application (2021-2026)
Table 46. Europe Sevoflurane Sales by Company (2021-2026) & (K Units)
Table 47. Europe Sevoflurane Sales Market Share by Company (2021-2026)
Table 48. Europe Sevoflurane Revenue by Company (2021-2026) & (US$ Million)
Table 49. Europe Sevoflurane Revenue Market Share by Company (2021-2026)
Table 50. Europe Sevoflurane Sales by Type (2021-2026) & (K Units)
Table 51. Europe Sevoflurane Sales Market Share by Type (2021-2026)
Table 52. Europe Sevoflurane Sales by Application (2021-2026) & (K Units)
Table 53. Europe Sevoflurane Sales Market Share by Application (2021-2026)
Table 54. China Sevoflurane Sales by Company (2021-2026) & (K Units)
Table 55. China Sevoflurane Sales Market Share by Company (2021-2026)
Table 56. China Sevoflurane Revenue by Company (2021-2026) & (US$ Million)
Table 57. China Sevoflurane Revenue Market Share by Company (2021-2026)
Table 58. China Sevoflurane Sales by Type (2021-2026) & (K Units)
Table 59. China Sevoflurane Sales Market Share by Type (2021-2026)
Table 60. China Sevoflurane Sales by Application (2021-2026) & (K Units)
Table 61. China Sevoflurane Sales Market Share by Application (2021-2026)
Table 62. Japan Sevoflurane Sales by Company (2021-2026) & (K Units)
Table 63. Japan Sevoflurane Sales Market Share by Company (2021-2026)
Table 64. Japan Sevoflurane Revenue by Company (2021-2026) & (US$ Million)
Table 65. Japan Sevoflurane Revenue Market Share by Company (2021-2026)
Table 66. Japan Sevoflurane Sales by Type (2021-2026) & (K Units)
Table 67. Japan Sevoflurane Sales Market Share by Type (2021-2026)
Table 68. Japan Sevoflurane Sales by Application (2021-2026) & (K Units)
Table 69. Japan Sevoflurane Sales Market Share by Application (2021-2026)
Table 70. India Sevoflurane Sales by Company (2021-2026) & (K Units)
Table 71. India Sevoflurane Sales Market Share by Company (2021-2026)
Table 72. India Sevoflurane Revenue by Company (2021-2026) & (US$ Million)
Table 73. India Sevoflurane Revenue Market Share by Company (2021-2026)
Table 74. India Sevoflurane Sales by Type (2021-2026) & (K Units)
Table 75. India Sevoflurane Sales Market Share by Type (2021-2026)
Table 76. India Sevoflurane Sales by Application (2021-2026) & (K Units)
Table 77. India Sevoflurane Sales Market Share by Application (2021-2026)
Table 78. Hengrui Company Information
Table 79. Hengrui Description and Business Overview
Table 80. Hengrui Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Hengrui Sevoflurane Product
Table 82. Hengrui Recent Development
Table 83. Baxter Company Information
Table 84. Baxter Description and Business Overview
Table 85. Baxter Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Baxter Sevoflurane Product
Table 87. Baxter Recent Development
Table 88. Maruishi Company Information
Table 89. Maruishi Description and Business Overview
Table 90. Maruishi Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Maruishi Sevoflurane Product
Table 92. Maruishi Recent Development
Table 93. AbbVie Company Information
Table 94. AbbVie Description and Business Overview
Table 95. AbbVie Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. AbbVie Sevoflurane Product
Table 97. AbbVie Recent Development
Table 98. Piramal Company Information
Table 99. Piramal Description and Business Overview
Table 100. Piramal Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Piramal Sevoflurane Product
Table 102. Piramal Recent Development
Table 103. Viatris Company Information
Table 104. Viatris Description and Business Overview
Table 105. Viatris Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Viatris Sevoflurane Product
Table 107. Viatris Recent Development
Table 108. PT Novell Pharmaceutical Company Information
Table 109. PT Novell Pharmaceutical Description and Business Overview
Table 110. PT Novell Pharmaceutical Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. PT Novell Pharmaceutical Sevoflurane Product
Table 112. PT Novell Pharmaceutical Recent Development
Table 113. Lunan Pharma Company Information
Table 114. Lunan Pharma Description and Business Overview
Table 115. Lunan Pharma Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Lunan Pharma Sevoflurane Product
Table 117. Lunan Pharma Recent Development
Table 118. Production Base and Market Concentration Rate of Raw Material
Table 119. Key Suppliers of Raw Materials
Table 120. Sevoflurane Distributors List
Table 121. Sevoflurane Customers List
Table 122. Sevoflurane Market Trends
Table 123. Sevoflurane Market Drivers
Table 124. Sevoflurane Market Challenges
Table 125. Sevoflurane Market Restraints
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Sevoflurane Product Picture
Figure 2. Global Sevoflurane Sales (US$ Million) by Type (2021, 2025 & 2032)
Figure 3. Global Sevoflurane Sales Market Share by Type in 2025 & 2032
Figure 4. Generic Drug Product Picture
Figure 5. Original Drug Product Picture
Figure 6. Global Sevoflurane Sales (US$ Million) by Application (2021, 2025 & 2032)
Figure 7. Global Sevoflurane Sales Market Share by Application in 2025 & 2032
Figure 8. Hospital Examples
Figure 9. Clinics Examples
Figure 10. Other Examples
Figure 11. Global Sevoflurane Sales, (US$ Million), 2021 VS 2025 VS 2032
Figure 12. Global Sevoflurane Sales Growth Rate (2021-2032) & (US$ Million)
Figure 13. Global Sevoflurane Sales (K Units) Growth Rate (2021-2032)
Figure 14. Global Sevoflurane Price Trends Growth Rate (2021-2032) & (US$/Unit)
Figure 15. Sevoflurane Report Years Considered
Figure 16. Global Market Sevoflurane Market Size (US$ Million) by Region:2021 VS 2025 VS 2032
Figure 17. Global Sevoflurane Revenue Market Share by Region: 2021 VS 2025
Figure 18. North America Sevoflurane Revenue (US$ Million) Growth Rate (2021-2032)
Figure 19. North America Sevoflurane Sales (K Units) Growth Rate (2021-2032)
Figure 20. Europe Sevoflurane Revenue (US$ Million) Growth Rate (2021-2032)
Figure 21. Europe Sevoflurane Sales (K Units) Growth Rate (2021-2032)
Figure 22. China Sevoflurane Revenue (US$ Million) Growth Rate (2021-2032)
Figure 23. China Sevoflurane Sales (K Units) Growth Rate (2021-2032)
Figure 24. Japan Sevoflurane Revenue (US$ Million) Growth Rate (2021-2032)
Figure 25. Japan Sevoflurane Sales (K Units) Growth Rate (2021-2032)
Figure 26. India Sevoflurane Revenue (US$ Million) Growth Rate (2021-2032)
Figure 27. India Sevoflurane Sales (K Units) Growth Rate (2021-2032)
Figure 28. Global Sevoflurane Revenue Share by Type (2021-2026)
Figure 29. Global Sevoflurane Sales Share by Type (2027-2032)
Figure 30. Global Sevoflurane Revenue Share by Type (2027-2032)
Figure 31. Global Sevoflurane Revenue Share by Application (2021-2026)
Figure 32. Global Sevoflurane Revenue Growth Rate by Application in 2021 & 2025
Figure 33. Global Sevoflurane Sales Share by Application (2027-2032)
Figure 34. Global Sevoflurane Revenue Share by Application (2027-2032)
Figure 35. Global Sevoflurane Sales Share by Company (2025)
Figure 36. Global Sevoflurane Revenue Share by Company (2025)
Figure 37. Global 5 Largest Sevoflurane Players Market Share by Revenue in Sevoflurane: 2021 & 2025
Figure 38. Sevoflurane Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 39. Manufacturing Cost Structure of Sevoflurane
Figure 40. Manufacturing Process Analysis of Sevoflurane
Figure 41. Sevoflurane Industrial Chain
Figure 42. Channels of Distribution (Direct Vs Distribution)
Figure 43. Distributors Profiles
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What is the annual compound growth rate of the global Sevoflurane market size from 2026 to 2032?
The annual compound growth rate of the global Sevoflurane market is 3.6% 2026 to 2032.
What was the global market size of Sevoflurane in 2032?
Which region is expected to have the highest market share?
Which companies rank high in the global Sevoflurane market?
What was the global market size of Sevoflurane in 2026?
Related Reports
Global Sevoflurane Market Research Report 2026
The global Sevoflurane market was valued at US$ 1234 million in 2025 and is anticipated to reach US$ 1577 million by 2032, at a CAGR of 3.6% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 113
USD 2900.00
(Single User License)
Sevoflurane- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Sevoflurane was estimated to be worth US$ 1234 million in 2025 and is projected to reach US$ 1577 million, growing at a CAGR of 3.6% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 94
USD 3950.00
(Single User License)
Global Sevoflurane Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Sevoflurane market is projected to grow from US$ 1195 million in 2024 to US$ 1527 million by 2031, at a CAGR of 3.6% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 134
USD 4900.00
(Single User License)
Global Sevoflurane Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Sevoflurane was estimated to be worth US$ 1195 million and is forecast to reach approximately US$ 1527 million by 2031 with a CAGR of 3.6% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 140
USD 5900.00
(Single User License)
Global Sevoflurane Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Sevoflurane market size was US$ 1195 million in 2024 and is forecast to a readjusted size of US$ 1527 million by 2031 with a CAGR of 3.6% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 78
USD 4250.00
(Single User License)
Sevoflurane- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Sevoflurane was estimated to be worth US$ 1195 million in 2024 and is forecast to a readjusted size of US$ 1527 million by 2031 with a CAGR of 3.6% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 93
USD 3950.00
(Single User License)
Global Sevoflurane Market Research Report 2025
The global market for Sevoflurane was valued at US$ 1195 million in the year 2024 and is projected to reach a revised size of US$ 1527 million by 2031, growing at a CAGR of 3.6% during the forecast period.
Published Date: 2025-01-16
Pages: 84
USD 2900.00
(Single User License)
Global and China Sevoflurane Market Report & Forecast 2024-2030
Sevoflurane is a volatile anesthetic commonly used for induction and maintenance of general anesthesia during surgical procedures. It is favored for its rapid onset and offset of action, making it ideal for both adults and pediatric patients. Sevoflurane is typically inhaled and works by depressing the central nervous system, leading to a reversible loss of consciousness and sensation. Its minimal airway irritation and low blood solubility contribute to smoother anesthesia induction and quicker recovery times compared to other anesthetics. Sevoflurane is widely used due to its safety profile and ease of administration.
Published Date: 2024-09-11
Pages: 105
USD 4350.00
(Single User License)
Sevoflurane- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sevoflurane is a volatile anesthetic commonly used for induction and maintenance of general anesthesia during surgical procedures. It is favored for its rapid onset and offset of action, making it ideal for both adults and pediatric patients. Sevoflurane is typically inhaled and works by depressing the central nervous system, leading to a reversible loss of consciousness and sensation. Its minimal airway irritation and low blood solubility contribute to smoother anesthesia induction and quicker recovery times compared to other anesthetics. Sevoflurane is widely used due to its safety profile and ease of administration.
Published Date: 2024-09-11
Pages: 107
USD 3950.00
(Single User License)
Global Sevoflurane Market Insights, Forecast to 2030
Sevoflurane is a volatile anesthetic commonly used for induction and maintenance of general anesthesia during surgical procedures. It is favored for its rapid onset and offset of action, making it ideal for both adults and pediatric patients. Sevoflurane is typically inhaled and works by depressing the central nervous system, leading to a reversible loss of consciousness and sensation. Its minimal airway irritation and low blood solubility contribute to smoother anesthesia induction and quicker recovery times compared to other anesthetics. Sevoflurane is widely used due to its safety profile and ease of administration.
Published Date: 2024-09-11
Pages: 135
USD 4900.00
(Single User License)
Global Sevoflurane Market Research Report 2026
The global Sevoflurane market was valued at US$ 1234 million in 2025 and is anticipated to reach US$ 1577 million by 2032, at a CAGR of 3.6% from 2026 to 2032.
Published: 2026-01-04
Pages: 113
USD 2900.00 (Single User License)Sevoflurane- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Sevoflurane was estimated to be worth US$ 1234 million in 2025 and is projected to reach US$ 1577 million, growing at a CAGR of 3.6% from 2026 to 2032.
Published: 2026-01-04
Pages: 94
USD 3950.00 (Single User License)Global Sevoflurane Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Sevoflurane market is projected to grow from US$ 1195 million in 2024 to US$ 1527 million by 2031, at a CAGR of 3.6% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 134
USD 4900.00 (Single User License)Global Sevoflurane Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Sevoflurane was estimated to be worth US$ 1195 million and is forecast to reach approximately US$ 1527 million by 2031 with a CAGR of 3.6% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 140
USD 5900.00 (Single User License)Global Sevoflurane Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Sevoflurane market size was US$ 1195 million in 2024 and is forecast to a readjusted size of US$ 1527 million by 2031 with a CAGR of 3.6% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 78
USD 4250.00 (Single User License)Sevoflurane- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Sevoflurane was estimated to be worth US$ 1195 million in 2024 and is forecast to a readjusted size of US$ 1527 million by 2031 with a CAGR of 3.6% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 93
USD 3950.00 (Single User License)Global Sevoflurane Market Research Report 2025
The global market for Sevoflurane was valued at US$ 1195 million in the year 2024 and is projected to reach a revised size of US$ 1527 million by 2031, growing at a CAGR of 3.6% during the forecast period.
Published: 2025-01-16
Pages: 84
USD 2900.00 (Single User License)Global and China Sevoflurane Market Report & Forecast 2024-2030
Sevoflurane is a volatile anesthetic commonly used for induction and maintenance of general anesthesia during surgical procedures. It is favored for its rapid onset and offset of action, making it ideal for both adults and pediatric patients. Sevoflurane is typically inhaled and works by depressing the central nervous system, leading to a reversible loss of consciousness and sensation. Its minimal airway irritation and low blood solubility contribute to smoother anesthesia induction and quicker recovery times compared to other anesthetics. Sevoflurane is widely used due to its safety profile and ease of administration.
Published: 2024-09-11
Pages: 105
USD 4350.00 (Single User License)Sevoflurane- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sevoflurane is a volatile anesthetic commonly used for induction and maintenance of general anesthesia during surgical procedures. It is favored for its rapid onset and offset of action, making it ideal for both adults and pediatric patients. Sevoflurane is typically inhaled and works by depressing the central nervous system, leading to a reversible loss of consciousness and sensation. Its minimal airway irritation and low blood solubility contribute to smoother anesthesia induction and quicker recovery times compared to other anesthetics. Sevoflurane is widely used due to its safety profile and ease of administration.
Published: 2024-09-11
Pages: 107
USD 3950.00 (Single User License)Global Sevoflurane Market Insights, Forecast to 2030
Sevoflurane is a volatile anesthetic commonly used for induction and maintenance of general anesthesia during surgical procedures. It is favored for its rapid onset and offset of action, making it ideal for both adults and pediatric patients. Sevoflurane is typically inhaled and works by depressing the central nervous system, leading to a reversible loss of consciousness and sensation. Its minimal airway irritation and low blood solubility contribute to smoother anesthesia induction and quicker recovery times compared to other anesthetics. Sevoflurane is widely used due to its safety profile and ease of administration.
Published: 2024-09-11
Pages: 135
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4250.00
USD 6375.00
USD 8500.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now